Atea Historical Financial Ratios
| AVIR Stock | USD 3.24 0.13 3.86% |
Atea Pharmaceuticals is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.43 or Days Sales Outstanding of 34.91 will help investors to properly organize and evaluate Atea Pharmaceuticals financial condition quickly.
Atea |
About Atea Financial Ratios Analysis
Atea PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Atea Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Atea financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Atea Pharmaceuticals history.
Atea Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Atea Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Atea Pharmaceuticals sales, a figure that is much harder to manipulate than other Atea Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Atea Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Atea Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.At this time, Atea Pharmaceuticals' Ebt Per Ebit is relatively stable compared to the past year.
| 2024 | 2025 (projected) | Graham Number | 14.07 | 7.42 | Receivables Turnover | 7.53 | 6.69 |
Atea Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Atea Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atea Pharmaceuticals fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 6.29 | 1.04 | 0.63 | 0.46 | 0.41 | 0.43 | |
| Book Value Per Share | 6.65 | 8.57 | 7.69 | 6.66 | 5.99 | 3.76 | |
| Free Cash Flow Yield | 0.0861 | (0.12) | (0.31) | (0.34) | (0.39) | (0.37) | |
| Operating Cash Flow Per Share | 3.6 | (1.05) | (1.45) | (1.02) | (1.18) | (1.12) | |
| Capex To Depreciation | 0.12 | 1.37 | 0.14 | 7.47 | 6.73 | 7.06 | |
| Pb Ratio | 6.29 | 1.04 | 0.63 | 0.46 | 0.41 | 0.43 | |
| Free Cash Flow Per Share | 3.6 | (1.05) | (1.48) | (1.02) | (1.18) | (1.12) | |
| Roic | (0.02) | 0.17 | (0.2) | (0.29) | (0.26) | (0.28) | |
| Net Income Per Share | (0.13) | 1.46 | (1.39) | (1.63) | (1.87) | (1.78) | |
| Payables Turnover | 0.32 | 0.006396 | 0.1 | 16.48 | 14.84 | 15.58 | |
| Cash Per Share | 10.31 | 9.23 | 13.27 | 6.93 | 6.24 | 5.43 | |
| Pocfratio | 11.61 | (8.51) | (3.31) | (2.98) | (2.68) | (2.81) | |
| Capex To Operating Cash Flow | (1.56E-4) | 8.8E-5 | (4.6E-5) | (0.0161) | (0.0185) | (0.0175) | |
| Pfcf Ratio | 11.61 | (8.51) | (3.26) | (2.98) | (2.68) | (2.81) | |
| Days Payables Outstanding | 1.2K | 57.1K | 3.6K | 22.14 | 25.46 | 24.19 | |
| Income Quality | (27.11) | (0.72) | 1.04 | 0.63 | 0.57 | 0.59 | |
| Roe | (0.0198) | 0.17 | (0.18) | (0.24) | (0.28) | (0.27) | |
| Ev To Operating Cash Flow | 8.74 | 0.27 | 2.01 | (1.32) | (1.19) | (1.25) | |
| Pe Ratio | (317.03) | 6.11 | (3.45) | (1.87) | (1.68) | (1.77) | |
| Return On Tangible Assets | (0.0126) | 0.16 | (0.17) | (0.23) | (0.21) | (0.22) | |
| Ev To Free Cash Flow | 8.74 | 0.27 | 1.98 | (1.32) | (1.19) | (1.25) | |
| Earnings Yield | (0.003154) | 0.16 | (0.29) | (0.53) | (0.61) | (0.58) | |
| Net Debt To E B I T D A | 77.21 | (5.52) | 5.81 | 1.18 | 1.36 | 1.29 | |
| Current Ratio | 2.73 | 13.58 | 35.77 | 18.24 | 16.41 | 13.21 | |
| Tangible Book Value Per Share | 6.65 | 8.57 | 7.69 | 6.66 | 5.99 | 3.76 | |
| Graham Number | 4.44 | 16.8 | 15.53 | 15.63 | 14.07 | 7.42 | |
| Shareholders Equity Per Share | 6.65 | 8.57 | 7.69 | 6.66 | 5.99 | 3.76 | |
| Capex Per Share | 2.4E-5 | 3.15E-4 | 4.8E-5 | 0.0233 | 0.021 | 0.0221 | |
| Graham Net Net | 6.53 | 8.47 | 12.96 | 6.46 | 5.81 | 4.41 | |
| Enterprise Value Over E B I T D A | (235.59) | (0.17) | 2.19 | (0.94) | (0.85) | (0.89) | |
| Price Earnings Ratio | (317.03) | 6.11 | (3.45) | (1.87) | (1.68) | (1.77) | |
| Price Book Value Ratio | 6.29 | 1.04 | 0.63 | 0.46 | 0.41 | 0.43 | |
| Days Of Payables Outstanding | 1.2K | 57.1K | 3.6K | 22.14 | 25.46 | 24.19 | |
| Price To Operating Cash Flows Ratio | 11.61 | (8.51) | (3.31) | (2.98) | (2.68) | (2.81) | |
| Price To Free Cash Flows Ratio | 11.61 | (8.51) | (3.26) | (2.98) | (2.68) | (2.81) | |
| Ebt Per Ebit | 0.99 | 1.0 | 0.91 | 0.82 | 0.95 | 1.03 |
Pair Trading with Atea Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
| 0.47 | MBFJF | Mitsubishi UFJ Financial | PairCorr |
| 0.44 | BMY | Bristol Myers Squibb | PairCorr |
| 0.42 | LH | Laboratory | PairCorr |
| 0.31 | GILD | Gilead Sciences | PairCorr |
The ability to find closely correlated positions to Atea Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea Pharmaceuticals to buy it.
The correlation of Atea Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.